Malta - inglés - Malta Medicines Authority

engelhard arzneimittel gmbh & co. kg herzbergstrasse 3 61138 niederdorfelden, germany - hedera helix - lozenge - hedera helix 26 mg - cough and cold preparations

Malta - inglés - Malta Medicines Authority

engelhard arzneimittel gmbh & co. kg herzbergstrasse 3 61138 niederdorfelden, germany - hedera helix - oral liquid - hedera helix 35 mg/5ml - cough and cold preparations

Malta - inglés - Malta Medicines Authority

engelhard arzneimittel gmbh & co. kg herzbergstrasse 3 61138 niederdorfelden, germany - chlorhexidine gluconate, tyrothricin, lidocaine hydrochloride - lozenge - tyrothricin 0.5 mg lidocaine hydrochloride 1 mg chlorhexidine gluconate 1 mg - throat preparations

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

cheplapharm arzneimittel gmbh - flumazenil - solution for injection/infusion - 500 micrograms/5ml - antidotes; flumazenil

Unión Europea - inglés - EMA (European Medicines Agency)

cheplapharm arzneimittel gmbh - colesevelam (as hydrochloride) - hypercholesterolemia - lipid modifying agents - cholestagel co-administered with a 3-hydroxy-3-methyl-glutaryl-coenzyme-a (hmg-coa)-reductase inhibitor (statin) is indicated as adjunctive therapy to diet to provide an additive reduction in low-density-lipoprotein-cholesterol (ldl-c) levels in adult patients with primary hypercholesterolaemia who are not adequately controlled with a statin alone.cholestagel as monotherapy is indicated as adjunctive therapy to diet for reduction of elevated total cholesterol and ldl-c in adult patients with primary hypercholesterolaemia, in whom a statin is considered inappropriate or is not well tolerated.cholestagel can also be used in combination with ezetimibe, with or without a statin, in adult patients with primary hypercholesterolaemia, including patients with familial hypercholesterolaemia (see section 5.1).

Unión Europea - inglés - EMA (European Medicines Agency)

archie samiel s.r.o. - clopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antithrombotic agents - clopidogrel is indicated in adults for the prevention of atherothrombotic events in:patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease;patients suffering from acute coronary syndrome:non-st-segment-elevation acute coronary syndrome (unstable angina or non-q wave-myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa);st-segment-elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy.

Estados Unidos - inglés - NLM (National Library of Medicine)

emergent biodefense operations lansing, llc - bacillus anthracis strain v770-np1-r antigens (unii: 873oi62848) (bacillus anthracis strain v770-np1-r antigens - unii:873oi62848) - bacillus anthracis strain v770-np1-r antigens 100 ug in 1 ml - biothrax is a vaccine indicated for the active immunization for the prevention of disease caused by bacillus anthracis in persons 18 through 65 years of age. the efficacy of biothrax for post-exposure prophylaxis is based solely on studies in animal models of inhalational anthrax. do not administer biothrax to individuals with a history of anaphylactic or anaphylactic-like reaction following a previous dose of biothrax or any component of the vaccine, including aluminum, benzethonium chloride, and formaldehyde. [see description (11).] pregnancy category d. [see warnings and precautions (5.3)] healthcare practitioners are encouraged to register women who receive biothrax during pregnancy in emergent’s vaccination pregnancy registry by calling 1-619-553-9255. male fertility: a retrospective study was performed at an in-vitro fertilization clinic to evaluate whether biothrax may impact reproductive function in men. this study compared semen parameters, embryo quality, and pregnancy outcomes in 254 male cli

Malta - inglés - Malta Medicines Authority

dr. friedrich eberth arzneimittel gmbh am bahnhof 2, ursensollen 92289, germany - cefuroxime sodium - powder for solution for infusion or injection - cefuroxime sodium 750 mg - antibacterials for systemic use

Malta - inglés - Malta Medicines Authority

dr. friedrich eberth arzneimittel gmbh am bahnhof 2, ursensollen 92289, germany - cefuroxime sodium - powder for solution for infusion or injection - cefuroxime sodium 1500 mg - antibacterials for systemic use

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

cheplapharm arzneimittel gmbh - phytomenadione - solution for injection - 10 milligram(s)/millilitre - vitamin k; phytomenadione